Azimilide Terminated Phase 3 Trials for Implantable Cardioverter Defibrillator (ICD) / Cardiovascular Disease (CVD) / Heart Diseases / Cardiac Dysrhythmia Treatment

IndicationsStatusPurposePhase
TerminatedTreatment3
clinicaltrials.gov IdentifierTitleDrugs
NCT01464476Efficacy and Safety Study of Azimilide on the Incidence of Cardiovascular Hospitalizations/Emergency Department Visits or Cardiovascular Death in Patients With an Implantable Cardioverter Defibrillator (ICD) (SHIELD-2)